November 21, 2009
Health
Tamiflu-resistant H1N1 cluster reported
Four people in North Carolina have tested positive for a type of swine flu that is resistant to the drug Tamiflu and may show signs the virus may be mutating.
Tamiflu-resistant swine flu cluster reported in NC
Health officials say four people in North Carolina have tested positive for a type of swine flu that's resistant to the drug Tamiflu. It's the first cluster of that many cases seen in the U.S.
Report: 20-somethings can go 2 years between Paps
New guidelines by the American College of Obstetricians and Gynecologists say most women in their 20s can have a Pap smear every two years instead of annually to catch slow-growing cervical cancer.
Military experiment seeks to predict PTSD
The U.S. Marine Corps is conducting a military experiment to try to predict who's most at risk for post-traumatic stress disorder. Understanding underlying triggers might help reduce the burden of those who return psychologically wounded - if they can get early help.
FDA panel backs safety, benefits of Spiriva
Federal health experts on Thursday brushed off lingering safety questions about a popular inhaler drug and suggested it carry bolder benefit claims.
Experts say radical measures won't stop swine flu
Health experts say extraordinary measures against swine flu - most notably quarantines imposed by China, where entire planeloads of passengers were isolated if one traveler had symptoms - have failed to contain the disease.
Study: CT scans rule out heart attacks faster
CT scans are increasingly used to diagnose problems because they give a deep, detailed view inside the body. But they put out a lot of radiation, which may raise a person's chances of developing cancer.
Task force doctor stands by mammogram advice
A member of the independent panel whose new mammogram recommendations have led to confusion defended the task force's report, saying Thursday that it was based on the most up-to-date, accurate information available.
FDA panel backs Pfizer's enhanced vaccine for kids
Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals.
Melaleuca to sue competitor
Melaleuca is going after one of its competitors in court.